CompaniespH Pharma

pH Pharma

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

5

As Collaborator

0

Total Enrollment

352

By Phase

PHASE3: 1PHASE1: 3PHASE2: 1

By Status

COMPLETED: 4UNKNOWN: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
Today
NCT03627845
NCT04863365
Hover over trial bars to see details

Recent Trials

NCT04863365Lead Sponsor
A Study of Efficacy and Safety of PHP-201 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
PHASE3Unknown
110 participants
Started: Nov 30, 2021 · Completed: Nov 30, 2023
NCT03775278Lead Sponsor
A Study of Safety, Tolerability, and Pharmacokinetics of Multiple-Ascending Doses of PHP-303 in Otherwise Healthy Overweight or Obese Subjects
PHASE1Completed
50 participants
Started: Dec 17, 2018 · Completed: Apr 7, 2020
NCT03627845Lead Sponsor
A Study of Safety, Tolerability, and Pharmacokinetics of Single Doses of PHP-303 in Healthy Subjects
PHASE1Completed
49 participants
Started: Aug 2, 2018 · Completed: Jan 8, 2020
NCT03586908Lead Sponsor
PK/PD, Safety and Tolerability of PHP-201 Topical Eye Drop in Korean and Japanese Healthy Subjects
PHASE1Completed
24 participants
Started: Feb 4, 2018 · Completed: Mar 9, 2018
NCT03106532Lead Sponsor
Evaluation of PHP-201 Ophthalmic Solution in Patients With Normal Tension Glaucoma
PHASE2Completed
119 participants
Started: Mar 6, 2017 · Completed: May 2, 2018